A key federal vaccine advisory panel whose members were recently replaced by Health and Human Services Secretary Robert F. Kennedy Jr. is expected to vote to recommend delaying until age 4 the hepatitis B vaccine that\u2019s currently given to newborns, according to two former senior Centers for Disease Control and Prevention officials.<\/p>\n
\u201cThere is going to likely be a discussion about hepatitis B vaccine, very specifically trying to dislodge the birth dose of hepatitis B vaccine and to push it later in life,\u201d said Demetre Daskalakis, former director<\/a> of the National Center for Immunization and Respiratory Diseases. \u201cApparently this is a priority of the secretary\u2019s.\u201d<\/p>\n The vote is expected to take place during the next meeting of the CDC\u2019s Advisory Committee on Immunization Practices, scheduled for Sept. 18-19.<\/p>\n For more than 30 years, the first of three shots of hepatitis B vaccine has been recommended for infants shortly after birth. In that time, the potentially fatal disease has been virtually eradicated among American children. Pediatricians warn that waiting four years for the vaccine opens the door to more children contracting the virus.<\/p>\n \u201cAge 4 makes zero sense,\u201d pediatrician Eric Ball said. \u201cWe recommend a universal approach to prevent those cases where a test might be incorrect or a mother might have unknowingly contracted hepatitis. It\u2019s really the best way to keep our entire population healthy.\u201d<\/p>\n In addition to the hepatitis B vaccine, the panel will also discuss<\/a> and vote on recommendations for the combined measles, mumps, rubella, and varicella vaccine and covid-19 vaccines. Pediatricians worry changes to the schedules of these vaccines will limit access for many families, leaving them vulnerable to vaccine-preventable diseases.<\/p>\n Typically, ACIP would undertake an analysis of the data before recommending a change to vaccine guidelines. As of the end of August, this process had not begun for the hepatitis B vaccines, Daskalakis and another former official said.<\/p>\n \u201cThis is an atypical situation. There\u2019s been no work group to discuss it,\u201d Daskalakis said.<\/p>\n The second former senior official spoke to NPR and KFF Health News on the condition of anonymity.<\/p>\n In response to questions from KFF Health News, HHS spokesperson Andrew Nixon wrote, \u201cACIP exists to ensure that vaccine policy is guided by the best available evidence and open scientific deliberation. Any updates to recommendations will be made transparently with gold standard science.\u201d<\/p>\n The draft agenda for the upcoming ACIP meeting was released to the public less than a week before it is scheduled to begin.<\/p>\n At the last ACIP meeting, in June, Martin Kulldorff, the chair and one of seven new members handpicked by Kennedy, questioned the need to vaccinate every newborn, citing only two of the many ways the virus can spread. Kulldorff is a former Harvard Medical School professor who became known for opposing some public health measures<\/a> during the pandemic.<\/p>\n \u201cUnless the mother is hepatitis B positive, an argument could be made to delay the vaccine for this infection, which is primarily spread by sexual activity and intravenous drug use,\u201d he said.<\/p>\n The virus spreads via direct exposure to an infected bodily fluid like blood or semen. The disease has no cure and can lead to serious conditions like cirrhosis and liver cancer later in life. The CDC advisory panel may maintain the recommendation to inoculate newborns whose mothers have hepatitis B or are considered at high risk of the disease, the former officials said.<\/p>\n Protection From Birth<\/strong><\/p>\n In 1991, federal health officials determined it was advisable for newborns to receive their first dose of the hepatitis B vaccine within 24 hours of birth<\/a>, which blocks the virus from taking hold if transmitted during delivery. While parents may opt out of the shots, many day care centers and school districts require proof<\/a> of hepatitis B vaccination for enrollment.<\/p>\n The prospect of ACIP\u2019s altering the recommendation has left some people living with the virus deeply unsettled.<\/p>\n \u201cI am goddamn frustrated,\u201d said Wendy Lo, who has lived with the liver disease, likely since birth. Years of navigating the psychological, monetary, medical, and social aspects of chronic hepatitis B has touched almost every aspect of her life.<\/p>\n \u201cI would not want anyone to have to experience that if it can be prevented,\u201d she said. Lo learned she had the disease due to a routine screening to study abroad in college.<\/p>\n Lo credits the vaccines with protecting her close family members from infection.<\/p>\n \u201cI shared with my partner, \u2018If you get vaccinated, we can be together,\u2019\u201d she said. He got the vaccine, which protects him from infection, \u201cso I\u2019m grateful for that,\u201d she said.<\/p>\n The CDC estimates half of people with hepatitis B do not know<\/a> they are infected. It can range from an acute, mild infection to a chronic infection, often with few to no symptoms<\/a>. Most people with chronic hepatitis B were born outside of the U.S., and Asians and Pacific Islanders followed by<\/a> Black people have the highest rates of newly reported chronic infections.<\/p>\n When her children were born, Lo was adamant that they receive the newborn dose, a decision she says prevented them from contracting the virus.<\/p>\n The earlier an infection occurs, the worse the consequences<\/a>, according to the CDC. When contracted in infancy or early childhood, hepatitis B is far more likely to become a chronic infection, silently damaging the liver over decades.<\/p>\n Those who become chronic carriers can also unknowingly spread the virus to others and face an increased risk of long-term complications including cirrhosis and liver cancer, which may not become evident until much later in life.<\/p>\n \u201cNow I\u2019m in my 50s, one of my big concerns is liver cancer. The vaccine is safe and effective, it\u2019s lifesaving, and it protects you against cancer. How many vaccines do that?\u201d Lo said.<\/p>\n Thirty Years of Universal Vaccination<\/strong><\/p>\n Treatments like the antivirals Lo now takes weren\u2019t available until the 1990s. Decades of the virus\u2019s replicating unchecked damaged her liver. Every six months she gets scared of what her blood tests may reveal.<\/p>\n After a vaccine was approved in the 1980s, public health officials initially focused vaccination efforts on people thought to be at highest risk of infection.<\/p>\n \u201cI, and every other doctor, had been trained in medical school to think of hepatitis B as an infection you acquired as an adult. It was the pimps, the prostitutes, the prisoners, and the health care practitioners who got hepatitis B infection. But we\u2019ve learned so much more,\u201d said William Schaffner<\/a>, a professor of infectious diseases at the Vanderbilt University School of Medicine and a former voting member of ACIP.<\/p>\n As hepatitis B rates remained stubbornly high in the 1980s, scientists realized an entire vulnerable group was missing from the vaccination regime \u2014 newborns. The virus is often transmitted<\/a> from an infected mother to baby in late pregnancy or during birth.<\/p>\n \u201cWe may soon hear, \u2018Let\u2019s just do a blood test on all pregnant women.\u2019 We tried that. That doesn\u2019t work perfectly either,\u201d Schaffner said.<\/p>\n Some doctors didn\u2019t test, he said, and some pregnant women falsely tested negative while others acquired hepatitis B after they had been tested earlier in their pregnancies.<\/p>\n In 1991, Schaffner was a liaison representative to ACIP when it voted to advise universal vaccination<\/a> for hepatitis B before an infant leaves the hospital.<\/p>\n \u201cWe want no babies infected. Therefore, we\u2019ll just vaccinate every mom and every baby at birth. Problem solved. It has been brilliantly successful in virtually eliminating hepatitis B in children,\u201d he said.<\/p>\n In 1990, there were 3.03 cases of hepatitis B per 100,000 people 19 years old or under in the U.S., according to the CDC.<\/p>\n Since the federal recommendation to vaccinate all infants, cases have dramatically decreased. CDC data<\/a> shows that in 2022 the rate among those 19 or under was less than 0.1 per 100,000.<\/p>\n While hepatitis B is often associated with high-risk behaviors such as injection drug use or having multiple sexual partners, health experts<\/a> note that it is possible for the virus to be transmitted in ordinary situations too, including among young children.<\/p>\n The virus can survive for up to seven days<\/a> outside the body. During that time, even microscopic traces of infected blood on a school desk or playground equipment<\/a> can pose a risk. If the virus comes into contact with an open wound or the mucous membranes of the eyes, an infection can occur. This means that unvaccinated children not considered at high risk can still be exposed in everyday environments.<\/p>\n Future Access Uncertain<\/strong><\/p>\n If the CDC significantly alters its recommendation, health insurers would no longer be required to cover the cost of the shots. That could leave parents to pay out-of-pocket for a vaccine that has long been provided at no charge. Children who get immunizations through the federal Vaccines for Children<\/a> program would lose free access to the shot as soon as any new ACIP recommendations get approved by the acting CDC director.<\/p>\n The two former CDC officials said that plans were underway to push back the official recommendation for the vaccine as of August, when they both left the agency, but may have changed.<\/p>\n Schaffner is still an alternate liaison member of ACIP, and hopes to express his support for universal newborn vaccination at the next meeting.<\/p>\n \u201cThe liaisons have now been excluded from the vaccine work groups. They are still permitted to attend the full meetings,\u201d he said.<\/p>\n Schaffner is worried about the next generation of babies and the doctors who care for them.<\/p>\n \u201cWe\u2019ll see cases of hepatitis B once again occur. We\u2019ll see transmission into the next generation,\u201d he said, \u201cand the next generation of people who wear white coats will have to deal with hepatitis B, when we could have cut it off at the pass.\u201d<\/p>\n We\u2019d like to speak with current and former personnel from the Department of Health and Human Services or its component agencies who believe the public should understand the impact of what\u2019s happening within the federal health bureaucracy. Please message KFF Health News on Signal at (415) 519-8778 or get in touch here<\/a><\/strong>.<\/em><\/p>\n KFF Health News<\/a> is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF\u2014an independent source of health policy research, polling, and journalism. Learn more about KFF<\/a>.<\/p>\nUSE OUR CONTENT<\/h3>\n